PRACTICAL study


PeRsonalised Asthma Combination Therapy; with Inhaled Corticosteroid and fast onset Long acting beta agonist study (PRACTICAL)

Registration: approved

Ethics: approved

This study is investigating the effectiveness of two different inhaler regimens in people with asthma who are aged between 18 and 75.

We have particularly high rates of asthma in New Zealand. At the moment, we are unsure as to which regimen is most beneficial for patients with asthma, which is why we are conducting this trial.

If you chose to take part, and are eligible for the study, you will be randomised to receive one of two inhaler regimens for one year. Either a Symbicort inhaler for relief of symptoms when you need it, or a regular preventer Pulmicort inhaler and Bricanyl inhaler for relief of symptoms.

We will be recruiting nearly 900 patients in total, from centres nationwide.

To take part in this study you must:

Be aged between 18 to 75

Have been diagnosed with asthma by your GP


You will will not be able to take part in the study if:

You are pregnant or breastfeeding

You have ever been admitted to Intensive care with life threatening asthma

You have had any steroids in the past 6 weeks

You have any additional lung conditions, such as COPD or Bronchiectasis

You will be asked to visit 6 times in total to complete questionnaires and perform breathing tests. Treatment will be provided at no charge and you will be reimbursed for travel and your time.

For more information please contact:

Jo Hardy

Jo.hardy@mrinz.ac.nz

04 805 4287

PRACTICAL study


PeRsonalised Asthma Combination Therapy; with Inhaled Corticosteroid and fast onset Long acting beta agonist study (PRACTICAL)

Registration: approved

Ethics: approved

This study is investigating the effectiveness of two different inhaler regimens in people with asthma who are aged between 18 and 75.

We have particularly high rates of asthma in New Zealand. At the moment, we are unsure as to which regimen is most beneficial for patients with asthma, which is why we are conducting this trial.

If you chose to take part, and are eligible for the study, you will be randomised to receive one of two inhaler regimens for one year. Either a Symbicort inhaler for relief of symptoms when you need it, or a regular preventer Pulmicort inhaler and Bricanyl inhaler for relief of symptoms.

We will be recruiting nearly 900 patients in total, from centres nationwide.

To take part in this study you must:

Be aged between 18 to 75

Have been diagnosed with asthma by your GP


You will will not be able to take part in the study if:

You are pregnant or breastfeeding

You have ever been admitted to Intensive care with life threatening asthma

You have had any steroids in the past 6 weeks

You have any additional lung conditions, such as COPD or Bronchiectasis

You will be asked to visit 6 times in total to complete questionnaires and perform breathing tests. Treatment will be provided at no charge and you will be reimbursed for travel and your time.

For more information please contact:

Jo Hardy

Jo.hardy@mrinz.ac.nz

04 805 4287

PRACTICAL study


PeRsonalised Asthma Combination Therapy; with Inhaled Corticosteroid and fast onset Long acting beta agonist study (PRACTICAL)

Registration: approved

Ethics: approved

This study is investigating the effectiveness of two different inhaler regimens in people with asthma who are aged between 18 and 75.

We have particularly high rates of asthma in New Zealand. At the moment, we are unsure as to which regimen is most beneficial for patients with asthma, which is why we are conducting this trial.

If you chose to take part, and are eligible for the study, you will be randomised to receive one of two inhaler regimens for one year. Either a Symbicort inhaler for relief of symptoms when you need it, or a regular preventer Pulmicort inhaler and Bricanyl inhaler for relief of symptoms.

We will be recruiting nearly 900 patients in total, from centres nationwide.

To take part in this study you must:

Be aged between 18 to 75

Have been diagnosed with asthma by your GP


You will will not be able to take part in the study if:

You are pregnant or breastfeeding

You have ever been admitted to Intensive care with life threatening asthma

You have had any steroids in the past 6 weeks

You have any additional lung conditions, such as COPD or Bronchiectasis

You will be asked to visit 6 times in total to complete questionnaires and perform breathing tests. Treatment will be provided at no charge and you will be reimbursed for travel and your time.

For more information please contact:

Jo Hardy

Jo.hardy@mrinz.ac.nz

04 805 4287

 
© 2017 MRINZ | Site map | Search | Terms & Conditions
Powered by Rainbow Creative | 23 Aug 2017 | Admin
M
L
X